Occulogix, Inc. - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Occulogix, Inc.. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Occulogix, Inc.. The Group's principal activity is to provide therapeutic treatments for eye diseases, including age-related macular degeneration or AMD. AMD is a chronic, progressive disease of the macular, or the central part of the retina, that results in the loss of central vision, and cannot be corrected by refractive means, such as glasses, contact lenses or laser eye surgery. The Group's major product is the RHEO system, which is designed to improve microcirculation in the eye by filtering high molecular weight proteins and other macromolecules from the patient's plasma. This system is used to perform Rheopheresis, a blood filtration process that selectively removes molecules from plasma. The trademarks of the Group include RHEO Therapy and Rheologix. The major customer of the Group is RHEO Clinic Inc. Currently, the Group generates its revenues only through operations in Canada.

Not the Report you are looking for? Click here for more browsing options.

$600/yr | Annual Subscription | Premium Access to more than 150,000 company reports for $600/year**

$59.99/mo | Monthly Subscription | Premium Access to more than 150,000 company reports for $59.99/month**

$39.95 | ALL Reports on this company | Buy all reports for Occulogix, Inc.

$24.95 | Single Price Analysis Report | Buy this Occulogix, Inc. Price Analysis

Set Currency* Argentinian Pesos Australian Dollars Bermudan Dollars Brazilian Reals Canadian Dollars Chilean Pesos Chinese Renmimbi Colombian Pesos Czech Koruni Danish Kroner Dirham Egyptian Pounds Euro Hong Kong Dollars Hungarian Forints Icelandic Kronas Indian Rupees Indonesian Rupiahs Israel Shekels Japanese Yen Jordanian Dinars Korean Won Malaysian Ringgits Mexican Pesos Moroccan Dirhams New Zealand Dollars Norwegian Kroner Pakistan Rupees Peruvian New Sols Philippine Pesos Polish New Zlotys Pounds Sterling Russian Rubles Saudi Riyals Singapore Dollars Slovak Koruni South African Rands Sri Lanka Rupees Swedish Kronor Swiss Francs Taiwanese Dollars Thai Bahts Turkish Liras U.S. Dollars Venezuelan Bolivars Zimbabwe Dollars * If a currency is not selected, the report will be delivered in the local currency of the company ** Premium access limits users to 500 reports per month

Layout and Content of a Typical Report